Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5658 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 14 15 16 ... 55 56 57  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Earlybird–SEVERAL: investment, 201608 first closing of Earlybird Health Tech Fund incl investors NRW.Bank + Generali + Miele + BMWE + Barmer GEK 2016-08-24
Ayoxxa–Märzhäuser: microplate reader, 201608 collab developm + contract manufacturing of Ayoxxa Reader AR01 by Märzhäuser 2016-08-22
Bruker Corp–FlavorActiV: food analysis, 201608– collab strategic partnership with launch of Flavor Stability Package for beer analysis 2016-08-15
InterHealth Nutraceuticals–Lonza: investment, 201608–201609 acquisition of InterHealth for up to $300m in upfront + earn-out from Kainos Capital 2016-08-15
Mologen–NN: business development services, 201608c– supply service to find outlicensing opportunities for lefitolimod 2016-08-11
Oculis–SEVERAL: investment, 201608 financing round Series A led by Brunnur Ventures + Silfurberg 2016-08-11
Thermo Fisher–Hamilton: liquid handling products, 201608– direct non-excl distribution of automation products for forensics in EMEA + China 2016-08-11
Werfen–Protagen: biomarker, 201608– license semi-excl for use of BICD2 biomarker for diagnosis of systemic sclerosis to Inova Diagnostics 2016-08-11
Gilead–Polyphor: drug discovery, 201608– collab + license agreem identifying + optimise drug candidates using macrocycle platform 2016-08-10
Akvolution–High-Tech Gründerfonds: investment, 201608 financing round Series A incl returning investor HTGF 2016-08-04
Akvolution–SEVERAL: investment, 201608 financing round Series A from HTGF + VNG Innovation + Bamag + private investors 2016-08-04
Oncgnostics–SEVERAL: investment, 201608–201606 crowdfunding campaign €500k via Seedmatch platform 2016-08-04
Arcus Biosciences–SEVERAL: investment, 201608 2nd financing round $70m led by new investor GV plus new + all existing investors 2016-08-01
ViraTherapeutics–Boehringer: investment, 201809 acquisition of all remaining shares of ViraTby BI with total transaction value of €210m 2016-08-01
Applied Micorarrays–Scienion: print/spotting technology, 201607– collab strategic partnership to support developm + production of IVD products 2016-07-28
Merck (DE)–Amoy Diagnostics: molecular diagnostics, 201607– collab developm liquid biopsy RAS biomarker CRC test based on ADx-SuperARMS for China 2016-07-28
Eurofins–Lablicate: mass spectrometry software, 201607 supply existent Eurofins is reference customer for OpenChrom s/w 2016-07-27
Symrise–Lablicate: mass spectrometry software, 201607 supply existent Symrise is reference customer for OpenChrom s/w 2016-07-27
Lophius–SEVERAL: investment, 201607 financing round €4.25m led by VRD GmbH + incl Bayern Kapital + Wolf Biotech + WIC GmbH 2016-07-26
Numares–Bavaria (govt): investment, 201607 financing round incl €2m from Wachstumsfonds Bayern managed by Bayern Kapital 2016-07-26
Numares–SEVERAL: investment, 201607 financing round incl €2m from Wachstumsfonds Bayern managed by Bayern Kapital 2016-07-26
InflaRx–SEVERAL: investment, 201607 financing round Series C €31m incl new investor Staidson Hongkong Investment Co Ltd 2016-07-21
Molecular Health–Akampion: public relations, 201607 service existent EMEA media + investor relations by Akampion 2016-07-21
Relypsa–Galenica: investment, 201607–201609 acquisition $1.53b cash tender offer $32/share 2016-07-21
Jounce Therapeutics–Nextech Invest: investment, 201607 existent investment of Nextech Oncology Fund IV 2016-07-20
Kura Oncology–Nextech Invest: investment, 201607 existent investment of Nextech Oncology Fund IV 2016-07-20
Nextech Invest–SEVERAL: investment, 201607 final closing of $64m Oncology Fund IV with Limited Partners in US + Europe + Asia 2016-07-20
Peloton Therapeutics–Nextech Invest: investment, 201607 existent investment of Nextech Oncology Fund IV 2016-07-20
ViroCyt–Sartorius: investment, 201607 acquisition valueing ViroCyt at $16m 2016-07-15
Boehringer–Univ Dundee: PROTAC technology, 201607– collab developm of PROTACs 2016-07-14
Pro Farma–Recordati: investment, 201607 acquisition CHF16m 100% of Pro Farma AG by Recordati 2016-07-14
RedoxTherapies–Juno Therapeutics: investment, 201607 acquisition $10m cash + milestones of RedoxTherapies by Juno 2016-07-14
Bayer–X-Chem: small-molecule drug discovery, 2016– collab extension of access to DEX technology up to $528m in upfront + r+d funding + milestones 2016-07-12
Delenex–Cell Medica: investment, 201607 acquisition €na of Delenex Pharmaceuticals AG by Cell Medica 2016-07-12
Valneva–EU (govt): credit, 201607 EIB RnD loan up to €25m in tranches within 24-months period to advance vaccine programs 2016-07-12
AMSilk–Kirchhoff Consult: public relations, 201607 service existent by Kirchhoff Consult AG 2016-07-11
AMSilk–SEVERAL: investment, 201607 financing round with existing investors MIG Fonds + AT Newtec 2016-07-11
Antibiotic Research UK–Evotec: drug discovery services, 201607– collab research €na to discovery antibiotic resistance breakers (ARBs) 2016-07-11
GenePOC–Debiopharm: investment, 201607 acquisition of majority share by acquiring all shares from Emerillon Capital + others 2016-07-11
Thomson Reuters–Onex Corp: investment, 201607–201610 acquisition $3.55b in cash of Thomson Reuters IP + Science business by Onex + Baring PE Asia 2016-07-11
CryoTherapeutics–Creathor Venture: investment, 201607 financing round Series B totalling €5.2m incl lead investor Creathor Venture 2016-07-07
CryoTherapeutics–Germany (govt): investment, 201607 financing round Series B totalling €5.2m incl returning co-investor KfW 2016-07-07
CryoTherapeutics–Getz Brothers: investment, 201607 financing round Series B totalling €5.2m incl returning co-investor Getz Brothers 2016-07-07
CryoTherapeutics–High-Tech Gründerfonds: investment, 201607 financing round Series B totalling €5.2m incl returning co-investor HTGF 2016-07-07
CryoTherapeutics–North Rhine-Westphalia (govt): investment, 201607 financing round Series B totalling €5.2m incl returning co-investor NRW.Bank 2016-07-07
CryoTherapeutics–Peppermint: investment, 201607 financing round Series B totalling €5.2m incl returning co-investor Peppermint CBF 2016-07-07
CryoTherapeutics–SEVERAL: investment, 201607 financing round Series B €5.2m led by Creathor incl NRW.Bank + Peppermint CBF + HTGF et al 2016-07-07
Evotec–MIT: CRISPR technology, 201607– research tool license non-excl to CRISPR-Cas9 gene editing technology from Broad Institute 2016-07-06
kSep Systems–Sartorius: investment, 201607 acquisition $28m of kSep Holdings Inc by SSB 2016-07-06
Nicox–GHO Capital: investment, 201607– acquisition €26m with €9m cash + €12m shares+loan notes + €5m milestones of Nicox commercial operations by GHO 2016-07-05
Global Bioenergies–Germany (govt): grant, 201607–201709 BMBF grant €400k for developm of renewable gasoline additives 2016-07-01
Denali Therapeutics–SEVERAL: investment, 201606 financing round Series B $130m led by Baillie Gifford + incl all founding plus new investors 2016-06-30
PBM Capital–Lonza: investment, 201606 acquisition of Triangle Research Labs LLC from PBM Capital Group 2016-06-30
Charles River–Caprotec: CCMS technology, 201606 collab use of CCMS tech to identify protein targets relevant for phenotypic drug candidate responses 2016-06-29
Evotec–Ellersbrook: investment, 201606– Ellersbrook will invest in Evotec’s internal TargetNASH programme 2016-06-29
Bruker Corp–Univ Greifswald: NMR spectroscopy, –201606 collab developm of B.I.-LISA module based on AVANCE IVDr platform w Prof Nauck 2016-06-28
Evotec–Genedata: bioinformatics, 201606– supply license Evotec using Genedata Screener now in HTS + HCS 2016-06-28
IntelliCyt–Sartorius: investment, 201606 acquisition for $90m in cash incl $5m in future tax savings 2016-06-28
Novartis–Xencor: antibody technology, 201606– collab + license $150m upfront + cost-sharing developm of biospecific antibodies for cancer 2016-06-28
Storm Therapeutics–Merck (DE): investment, 201606 financing round Series A totalling £12m incl investor Merck Ventures 2016-06-28
Storm Therapeutics–SEVERAL: investment, 201606 financing round Series A £12m with CIC + Merck Ventures + Pfizer Venture + Touchstone Innovations 2016-06-28
Cosmo Pharmaceuticals–Paion: remimazolam, 201606– license excl €10m upfront + €42.5m milestones + royalties for developm + commercialisation in US 2016-06-24
CRISPR Therapeutics–SEVERAL: investment, 201606 financing round Series B additional $38m closing from new investors 2016-06-24
Paion–Cosmo Pharmaceuticals: investment, 201606 investment as part of license agreem w Cosmo becoming largest shareholder holding 9.09% 2016-06-24
IFM Therapeutics–Abingworth: investment, 201606 financing round Series A totalling $27m incl lead investors Atlas Venture + Abingworth 2016-06-22
IFM Therapeutics–Atlas Venture: investment, 201606 financing round Series A totalling $27m incl lead investors Atlas Venture + Abingworth 2016-06-22
IFM Therapeutics–Novartis: investment, 201606 financing round Series A totalling $27m incl co-investor Novartis 2016-06-22
IFM Therapeutics–SEVERAL: investment, 201606 financing round Series A $27m led by Atlas Venture + Abingworth + incl Novartis 2016-06-22
Qiagen–Barclays: financial services, 201606 supply financial advisor to Qiagen with regard to offer for Exiqon AS 2016-06-22
MetaSUB project–Qiagen: genomic sample preparation, 201606– collab project using Qiagen sample tech + library prepration workflows 2016-06-21
F2G Ltd–SEVERAL: investment, 201606 financing round $60m led by Sector Asset Management 2016-06-20
Allecra Therapeutics–Delos Capital: investment, 201606 financing round Series B totalling €22m incl new + lead investor Delos Capital 2016-06-16
Allecra Therapeutics–Forbion: investment, 201606 financing round Series B totalling €22m incl returning co-investor FCF II Co-Invest I fund 2016-06-16
Allecra Therapeutics–SEVERAL: investment, 201606 financing round Series B €22m led by new investor Delos Capital 2016-06-16
Gilde Investment–SEVERAL: investment, 201606 final close of €250m Gilde Healthcare IV fund incl cornernstone investor Philips 2016-06-14
Univ Manchester–Danaher: mass spectrometer, 201606 supply Sciex Lipidyzer Platform to Stoller Centre 2016-06-13
Bluebird Bio–Lonza: contract manufacturing, 201606– collab long-term commercial manufacturing of Lenti-D + LentiGlobin drug products by Lonza Houston 2016-06-09
CRISPR Therapeutics–Anagenesis: cell therapy, 201606– strategic collab + ww excl license to P2MC technology for cell therapy for muscle diseases 2016-06-08
Sony–Stratec: investment, 201606–201607 acquisition €30m 100% of Sony DADC BioSciences business by Stratec 2016-06-08
F-Star–CMC Biologics: contract manufacturing, 201606– service manufacturing of mAb² bispecific antibodies by CMC Biologics 2016-06-07
Bruker Corp–Scripps Research Institute: mass spectrometry, –201606 collab development of MetaboBASE Personal Library w Center for Metabolomics 2016-06-06
Dr. Falk Pharma–Cosmo Pharmaceuticals: antibiotic, 201606– license existent for Rifamycin SV MMX for EU + Australia 2016-06-06
DSM–Bruker Corp: mass spectrometer, 201606 supply existent DSM Resolve early user of timsTOF system 2016-06-06
Florida State Univ–Bruker Corp: mass spectrometer, 201606 supply existent Prof Bleiholder at Dept Chemistry early user of timsTOF system 2016-06-06
Max Planck–Bruker Corp: mass spectrometer, 201606 supply existent MPI for Biophysics Ffm early user of rapifleX MALDI-TOF/TOF system 2016-06-06
Scripps Research Institute–Bruker Corp: mass spectrometer, 201606 supply existent recently installed impact QTOF system at Center for Metabolomics 2016-06-06
Univ Rouen–Bruker Corp: mass spectrometer, 201606 supply existent Univ Rouen early user of timsTOF system 2016-06-06
Pieris–SEVERAL: investment, 201606 private placement $16.5m w 8.18m units (shares + warrants) at $2.015/unit led by BVF Partners 2016-06-03
Grünenthal–AstraZeneca: lesinurad, 201606– license excl for Europe + Latin America to Zurampic + fixed dose combi of lesinurad + allopurinol 2016-06-02
Thermo Fisher–908 Devices: sample separation technology, 201606 collab integration of ZipChip microfluidics separation with Orbitrap MS systems 2016-06-02
Boehringer–Harvard Univ: drug research, 201606– collab research alliance 3y €na for novel treatments for severe fibrotic diseases 2016-06-01
Emperra–Germany (govt): business development, 201606– supply service support in US with German Accelerator Life Sciences programme 2016-06-01
ERS Genomics–MacDougall Biomedical Communications: public relations, 201606 service existent by MacDougall 2016-06-01
TxCell–Univ Lübeck: cell therapy, 201606– collab €na developm of CAR-Treg cells to treat bullous pemphigoid with LIED 2016-06-01
Hyglos–Mérieux: investment, 201605 acquisition 100% of Hyglos by bioMérieux for €24m phased over 3 years 2016-05-31
Link Health–4SC: cancer drug, 201605– collab license + developm partnership for 4SC-205 in Greater China 2016-05-31
Sividon Diagnostics–Myriad: investment, 201605 acquisition for €35m upfront + €15m milestones 2016-05-31
Aleva Neurotherapeutics–SEVERAL: investment, 201605 financing round Series C $18m incl $5m from strategic lead investor Greatbatch Inc 2016-05-27
Qiagen–Therawis: molecular companion diagnostics, 201605– license + co-developm predictive oncology tests w initial project using PITX2 assay 2016-05-25
Axela–Scienion: print/spotting technology, 201605– collab developm + marketing of production systems + services for diagnostics + research 2016-05-24
next pagenext page 1 2 3 ... 14 15 16 ... 55 56 57  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top